Skip to main content
Top
Published in: Rheumatology International 10/2012

01-10-2012 | Short Communication

Monoclonal gammopathies in a Moroccan military hospital

Authors: Z. Ouzzif, K. Doghmi, S. Bouhsain, A. Dami, S. El Machtani, S. Tellal, N. Messaoudi, M. Mikdame, A. El Maataoui

Published in: Rheumatology International | Issue 10/2012

Login to get access

Abstract

The aim of this study was to describe biological features and aetiology of monoclonal gammopathy diagnosed during a 10-year period in the biochemistry department of the Moroccan Military Hospital Mohamed V in Rabat. The study was performed from 1 January 2000 to 31 December 2009. The records of 261 patients living in the Rabat area in which either serum protein electrophoresis and serum and/or urine immunofixation were performed at the biochemistry department of Military Instruction Hospital in Rabat were analysed. A cohort of 182 (70%) men and 79 (30%) women, the mean ± SD (range) ages were 60.21 ± 12.56 years. All patients were Caucasian. Electrophoresis found that 211 (80.84%) of the patients had a monoclonal gammopathy. Immunofixation confirmed that 251 (96.17%) patients had a monoclonal band in serum. In our cohort, MM was the most frequent diagnosis, our patients were late diagnosed.
Literature
1.
go back to reference Attaelmannan M, Levinson SS (2000) Understanding and identifying monoclonal gammopathies. Clin Chem 46:1230–1238PubMed Attaelmannan M, Levinson SS (2000) Understanding and identifying monoclonal gammopathies. Clin Chem 46:1230–1238PubMed
2.
go back to reference Durie BG, Salmon SE (1975) A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer 36:842–854PubMedCrossRef Durie BG, Salmon SE (1975) A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer 36:842–854PubMedCrossRef
3.
go back to reference Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR et al (2006) Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 354:1362–1369PubMedCrossRef Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR et al (2006) Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 354:1362–1369PubMedCrossRef
4.
go back to reference Ogmundsdottir HM, Haraldsdottir V, Johannesson G, Olafsdottir G, Bjamadottir K, Sigvaldason H et al (2002) Monoclonal gammopathy in Iceland: a population-based registry and follow-up. Br J Haematol 118:166–173 Ogmundsdottir HM, Haraldsdottir V, Johannesson G, Olafsdottir G, Bjamadottir K, Sigvaldason H et al (2002) Monoclonal gammopathy in Iceland: a population-based registry and follow-up. Br J Haematol 118:166–173
5.
go back to reference Landgren O, Gridley G, Turesson I et al (2006) Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood 107(3):904–906 (Epub 2005 Oct 6) Landgren O, Gridley G, Turesson I et al (2006) Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood 107(3):904–906 (Epub 2005 Oct 6)
6.
go back to reference Ola Landgren, S. Vincent Rajkumar et al (2007) Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. Mayo Clin Proc. 82(2):1468–1473 Ola Landgren, S. Vincent Rajkumar et al (2007) Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. Mayo Clin Proc. 82(2):1468–1473
7.
go back to reference Kyle RA (1999) Sequence of testing for monoclonal gammopathies. Arch Pathol Lab Med 123:114–118PubMed Kyle RA (1999) Sequence of testing for monoclonal gammopathies. Arch Pathol Lab Med 123:114–118PubMed
8.
go back to reference Groves FD, Travis LB, Devessa SS et al (1998) Waldenström’s macroglobulinemia: incidence patterns in the United States, 1988–1994. Cancer 82:1078–1081PubMedCrossRef Groves FD, Travis LB, Devessa SS et al (1998) Waldenström’s macroglobulinemia: incidence patterns in the United States, 1988–1994. Cancer 82:1078–1081PubMedCrossRef
9.
go back to reference Decaux O, Rodon P, Ruelland A, Estepa L, Leblay R, Grosbois B (2007) Epidemiology of monoclonal gammopathy in a general hospital, a university internal medicine department. Rev Med Interne 28:670–676 Decaux O, Rodon P, Ruelland A, Estepa L, Leblay R, Grosbois B (2007) Epidemiology of monoclonal gammopathy in a general hospital, a university internal medicine department. Rev Med Interne 28:670–676
10.
go back to reference Iowa Surveillance, Epidemiology, and End-Results SEER Registry. 1973–1998 Iowa Surveillance, Epidemiology, and End-Results SEER Registry. 1973–1998
11.
go back to reference Hideshima T, Mitsiades C, Tonon G, Richardson PG, Anderson KC (2007) Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer 7:585–598PubMedCrossRef Hideshima T, Mitsiades C, Tonon G, Richardson PG, Anderson KC (2007) Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer 7:585–598PubMedCrossRef
12.
go back to reference Schwartzberg L (2007) Managed care considerations in the treatment of multiple myeloma. Managed Care Oncol 3:14–16, 47 Schwartzberg L (2007) Managed care considerations in the treatment of multiple myeloma. Managed Care Oncol 3:14–16, 47
13.
go back to reference Bradwell A (2006) Serum free light chain analysis, 4th edn. The Binding Site Ltd., Birmingham Bradwell A (2006) Serum free light chain analysis, 4th edn. The Binding Site Ltd., Birmingham
14.
go back to reference Mseddi-Hdiji S, Haddouk S, BenAyed M, Tahri N, Elloumi M, Baklouti S, Hachicha J, Krichen MS, Bahloul Z, Masmoudi H (2005) Monoclonal gammapathies in Tunisia: epidemiological, immunochemical and etiological analysis of 288 cases. Pathol Biol 53:19–25PubMedCrossRef Mseddi-Hdiji S, Haddouk S, BenAyed M, Tahri N, Elloumi M, Baklouti S, Hachicha J, Krichen MS, Bahloul Z, Masmoudi H (2005) Monoclonal gammapathies in Tunisia: epidemiological, immunochemical and etiological analysis of 288 cases. Pathol Biol 53:19–25PubMedCrossRef
15.
go back to reference Tamimi W, Alaskar A, Alassiri M, Alsaeed W, Alarifi SA, Alenzi FQ et al (2010) Monoclonal gammopathy in a tertiary referral hospital. Clin Biochem 43:709–713 Tamimi W, Alaskar A, Alassiri M, Alsaeed W, Alarifi SA, Alenzi FQ et al (2010) Monoclonal gammopathy in a tertiary referral hospital. Clin Biochem 43:709–713
Metadata
Title
Monoclonal gammopathies in a Moroccan military hospital
Authors
Z. Ouzzif
K. Doghmi
S. Bouhsain
A. Dami
S. El Machtani
S. Tellal
N. Messaoudi
M. Mikdame
A. El Maataoui
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 10/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2093-6

Other articles of this Issue 10/2012

Rheumatology International 10/2012 Go to the issue